Transcriptome profiling of the cancer, adjacent non-tumor and distant normal tissues from a colorectal cancer patient by deep sequencing

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Wu, Yan'an ^a   Wang, Xuetao ^a   Wu, Fangbo ^a   Huang, Ruolei ^a   Xue, Fangqin ^a   Liang, Guantao ^a   Tao, Min ^a   Cai, Pengwei ^a   Huang, Yi ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH2 RECEPTOR;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER TISSUE; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUSION; HIGH THROUGHPUT SEQUENCING; HIGH THROUGHPUT TRANSCRIPTOME SEQUENCING; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRTEN NOTCH2 GENE; QUANTITATIVE REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; TRANSCRIPTION REGULATION;

ALTERNATIVE SPLICING; CATENINS; CLUSTER ANALYSIS; COLON; COLORECTAL NEOPLASMS; EXONS; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MIDDLE AGED; MUCIN-4; PLATELET-DERIVED GROWTH FACTOR; PROTEIN ISOFORMS; RECEPTOR, NOTCH2; SEQUENCE ANALYSIS, DNA; SEQUENCE ANALYSIS, RNA; TRANSCRIPTOME;

EID: 84864660437     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041001     Document Type: Article

References (72)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96.
2. Wolpin BM, Mayer RJ, (2008) Systemic treatment of colorectal cancer. Gastroenterology 134: 1296-1310.
3. Dukes C, (1932) The classification of cancer of the rectum. Journal of Pathological Bacteriology 35: 323.
4. Markowitz SD, Dawson DM, Willis J, Willson JK, (2002) Focus on colon cancer. Cancer Cell 1: 233-236.
5. Bass AJ, Lawrence MS, Brace LE, Ramos AH, Drier Y, et al. (2011) Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion. Nat Genet 43: 964-968.
6. Ogino S, Nosho K, Irahara N, Shima K, Baba Y, et al. (2009) Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers. J Clin Oncol 27: 4591-4598.
7. Vogelstein B, Barber TD, McManus K, Yuen KWY, Reis M, et al. (2008) Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. Proceedings of the National Academy of Sciences of the United States of America 105: 3443-3448.
8. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, et al. (1994) Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368: 258-261.
9. Miyaki M, Konishi M, Tanaka K, Kikuchi-Yanoshita R, Muraoka M, et al. (1997) Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nature Genetics 17: 271-272.
10. Issa JP, (2004) CpG island methylator phenotype in cancer. Nat Rev Cancer 4: 988-993.
11. Kondo Y, Issa JP, (2004) Epigenetic changes in colorectal cancer. Cancer Metastasis Rev 23: 29-39.
12. Markowitz SD, Bertagnolli MM, (2009) Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 361: 2449-2460.
13. Davies RJ, Miller R, Coleman N, (2005) Colorectal cancer screening: prospects for molecular stool analysis. Nat Rev Cancer 5: 199-209.
14. Grade M, Hormann P, Becker S, Hummon AB, Wangsa D, et al. (2007) Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas (vol 67, pg 41, 2007). Cancer Research 67: 1877-1877.
15. Lothe RA, Kleivi K, Lind GE, Diep CB, Meling GI, et al. (2007) Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses. Molecular Cancer 6.
16. Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I, et al. (2009) Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 9: 489-499.
17. Bell D, Berchuck A, Birrer M, Chien J, Cramer D, et al. (2011) Integrated genomic analyses of ovarian carcinoma. Nature 474: 609-615.
18. Wong KM, Hudson TJ, McPherson JD, (2011) Unraveling the genetics of cancer: genome sequencing and beyond. Annu Rev Genomics Hum Genet 12: 407-430.
19. Metzker ML, (2010) Sequencing technologies - the next generation. Nat Rev Genet 11: 31-46.
20. Ozsolak F, Milos PM, (2011) RNA sequencing: advances, challenges and opportunities. Nat Rev Genet 12: 87-98.
21. Wang Z, Gerstein M, Snyder M, (2009) RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10: 57-63.
22. Berger MF, Levin JZ, Vijayendran K, Sivachenko A, Adiconis X, et al. (2010) Integrative analysis of the melanoma transcriptome. Genome Research 20: 413-427.
23. Maher CA, Kumar-Sinha C, Cao X, Kalyana-Sundaram S, Han B, et al. (2009) Transcriptome sequencing to detect gene fusions in cancer. Nature 458: 97-101.
24. Pflueger D, Terry S, Sboner A, Habegger L, Esgueva R, et al. (2011) Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing. Genome Research 21: 56-67.
25. Shah SP, Köbel M, Senz J, Morin RD, Clarke BA, et al. (2009) Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary. New England Journal of Medicine 360: 2719-2729.
26. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, et al. (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotech 28: 511-515.
27. Myung SJ, Rerko RM, Yan M, Platzer P, Guda K, et al. (2006) 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America 103: 12098-12102.
28. Gupta RA, Dubois RN, (2001) Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 1: 11-21.
29. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, et al. (1995) Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338.
30. Goss KH, Groden J, (2000) Biology of the adenomatous polyposis coli tumor suppressor. J Clin Oncol 18: 1967-1979.
31. Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, et al. (2002) Inherited variants of MYH associated with somatic G: C->T: A mutations in colorectal tumors. Nat Genet 30: 227-232.
32. Barault L, Charon-Barra C, Jooste V, de la Vega MF, Martin L, et al. (2008) Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. Cancer Research 68: 8541-8546.
33. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, et al. (1999) CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96: 8681-8686.
34. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, et al. (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75: 1027-1038.
35. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
36. Gout S, Huot J, (2008) Role of cancer microenvironment in metastasis: focus on colon cancer. Cancer Microenviron 1: 69-83.
37. Kessenbrock K, Plaks V, Werb Z, (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52-67.
38. Hsu PP, Sabatini DM, (2008) Cancer cell metabolism: Warburg and beyond. Cell 134: 703-707.
39. Vander Heiden MG, Cantley LC, Thompson CB, (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033.
40. David CJ, Manley JL, (2010) Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev 24: 2343-2364.
41. Venables JP, (2004) Aberrant and alternative splicing in cancer. Cancer Research 64: 7647-7654.
42. Katz Y, Wang ET, Airoldi EM, Burge CB, (2010) Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat Methods 7: 1009-1015.
43. Langer W, Sohler F, Leder G, Beckmann G, Seidel H, et al. (2010) Exon Array Analysis using re-defined probe sets results in reliable identification of alternatively spliced genes in non-small cell lung cancer. BMC Genomics 11: 676.
44. Dutertre M, Lacroix-Triki M, Driouch K, de la Grange P, Gratadou L, et al. (2010) Exon-Based Clustering of Murine Breast Tumor Transcriptomes Reveals Alternative Exons Whose Expression Is Associated with Metastasis. Cancer Research 70: 896-905.
45. Salomonis N, Nelson B, Vranizan K, Pico AR, Hanspers K, et al. (2009) Alternative Splicing in the Differentiation of Human Embryonic Stem Cells into Cardiac Precursors. PLoS Comput Biol 5: e1000553.
46. Klinakis A, Lobry C, Abdel-Wahab O, Oh P, Haeno H, et al. (2011) A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. Nature 473: 230-233.
47. Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, et al. (2011) Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333: 1154-1157.
48. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, et al. (2011) The mutational landscape of head and neck squamous cell carcinoma. Science 333: 1157-1160.
49. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B, (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Meth 5: 621-628.
50. Alon U, Barkai N, Notterman DA, Gish K, Ybarra S, et al. (1999) Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci U S A 96: 6745-6750.
51. Gardina PJ, Clark TA, Shimada B, Staples MK, Yang Q, et al. (2006) Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. BMC Genomics 7: 325.
52. Garber M, Grabherr MG, Guttman M, Trapnell C, (2011) Computational methods for transcriptome annotation and quantification using RNA-seq. Nat Meth 8: 469-477.
53. Trapnell C, Pachter L, Salzberg SL, (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25: 1105-1111.
54. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
55. Stetler-Stevenson WG, Aznavoorian S, Liotta LA, (1993) Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9: 541-573.
56. Skovbjerg H, Anthonsen D, Lothe IM, Tveit KM, Kure EH, et al. (2009) Collagen mRNA levels changes during colorectal cancer carcinogenesis. BMC Cancer 9: 136.
57. Sternlicht MD, Werb Z, (2001) How matrix metalloproteinases regulate cell behavior. Annual Review of Cell and Developmental Biology 17: 463-516.
58. Mook OR, Frederiks WM, Van Noorden CJ, (2004) The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 1705: 69-89.
59. Yi JM, Dhir M, Van Neste L, Downing SR, Jeschke J, et al. (2011) Genomic and epigenomic integration identifies a prognostic signature in colon cancer. Clin Cancer Res 17: 1535-1545.
60. Mitelman F, Johansson B, Mertens F, (2007) The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 7: 233-245.
61. McPherson A, Hormozdiari F, Zayed A, Giuliany R, Ha G, et al. (2011) deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data. PLoS Comput Biol 7: e1001138.
62. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, et al. (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310: 644-648.
63. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, et al. (2007) Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448: 561-566.
64. Chu D, Zhang Z, Zhou Y, Wang W, Li Y, et al. (2011) Notch1 and Notch2 have opposite prognostic effects on patients with colorectal cancer. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO 22: 2440-2447.
65. Chu D, Zheng J, Wang W, Zhao Q, Li Y, et al. (2009) Notch2 expression is decreased in colorectal cancer and related to tumor differentiation status. Ann Surg Oncol 16: 3259-3266.
66. Isidor B, Lindenbaum P, Pichon O, Bezieau S, Dina C, et al. (2011) Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis. Nat Genet 43: 306-308.
67. Jiang H, Wong WH, (2009) Statistical inferences for isoform expression in RNA-Seq. Bioinformatics 25: 1026-1032.
68. Hubbard TJP, Aken BL, Ayling S, Ballester B, Beal K, et al. (2009) Ensembl 2009. Nucleic Acids Research 37: D690-D697.
69. Kim D, Salzberg SL (2011) TopHat-Fusion: An algorithm for Discovery of Novel Fusion Transcripts. CSHL Biology of Genomes conference.
70. Steidl C, Shah SP, Woolcock BW, Rui L, Kawahara M, et al. (2011) MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 471: 377-381.
71. Cook NL, Vink R, Donkin JJ, van den Heuvel C, (2009) Validation of reference genes for normalization of real-time quantitative RT-PCR data in traumatic brain injury. J Neurosci Res 87: 34-41.
72. Barber TD, McManus K, Yuen KWY, Reis M, Parmigiani G, et al. (2008) Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. Proceedings of the National Academy of Sciences of the United States of America 105: 3443-3448.